Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|March 3, 2010
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirinMoises Diago, Mitchell L Shiffman, Jean-Pierre Bronowicki, et al.
Future Oncology (London, England)|July 10, 2015
Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON studyBruno Daniele, Adina Croitoru, Christos Papandreou, et al.
Journal of Hepatology|February 15, 2003
Rate of natural disease progression in patients with chronic hepatitis CJean-Pierre Zarski, John Mc Hutchison, Jean-Pierre Bronowicki, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
[Complementary treatments of chronic viral hepatitis C]Thierry Thevenot, Vincent Di Martino, Françoise Lunel-Fabiani, et al.
United European Gastroenterology Journal|April 14, 2017
25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patientsArthur Belle, Emmanuel Gizard, Guillaume Conroy, et al.
The American Journal of Gastroenterology|March 16, 2007
Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteineLaurent Peyrin-Biroulet, Rosa-Maria Rodriguez-Guéant, Mathias Chamaillard, et al.
Nutrition Research (New York, N.Y.)|January 27, 2019
Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patientsMaud Rizk, Adrien Guilloteau, Thomas Mouillot, et al.
Human Genomics|February 5, 2023
Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive casesTom Alix, Céline Chéry, Thomas Josse, et al.
Clinical Chemistry and Laboratory Medicine|September 11, 2003
Effects of vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in rat liverLaurent Brunaud, Jean-Marc Alberto, Ahmet Ayav, et al.
Oncotarget|December 10, 2017
The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenibGuillaume Conroy, Julia Salleron, Arthur Belle, et al.
Pageof 20